Treatment | Infection prevalence | Infectiousness | Sporozoite load | Oocyst load | ||||
---|---|---|---|---|---|---|---|---|
χ2 | P | χ2 | P | χ2 | P | χ2 | P | |
Competition | 0.43 | 0.51 | 0.13 | 0.71 | 3.79 | 0.053 | 12.64 | < 0.001 |
Larval exposure | 10.14 | 0.001 | 11.94 | < 0.001 | 0.07 | 0.78 | 4.53 | 0.035 |
Adult exposure | 8.24 | 0.004 | 5.64 | 0.018 | 1.681 | 0.20 | 4.22 | 0.042 |
Competition: larval exposure | 0.06 | 0.80 | 0.01 | 0.91 | 0.06 | 0.81 | 8.21 | 0.005 |
Competition:adult exposure | 0.17 | 0.68 | 0.01 | 0.94 | 0.38 | 0.54 | 1.05 | 0.31 |
Larval exposure: adult exposure | 7.87 | 0.005 | 6.38 | 0.011 | 0.18 | 0.67 | 0.46 | 0.50 |
Competition:larval exposure: adult exposure | 0.01 | 0.93 | 0.15 | 0.70 | 1.23 | 0.27 | 1.68 | 0.20 |